News

On April 9th, the ENLIGHT team met for the final consortium meeting at UMC Utrecht 🇳🇱. After four years of hard work, the project is now close to the finish line 🏁. 🔬 Using 3D printing, light-based technology, and synthetic biology, the goal is to improve how new treatments for diabetes are developed to create a bioprinted pancreas 🧬. At…

Read more

🚀  We are excited to share that Riccardo Levato and Jorge Madrid-Wolff recently attended SPIE Photonics West 25 - 30 January 2025 in San Francisco, one of the leading conferences on photonics and optical technologies. This year’s event featured groundbreaking discussions on volumetric printing, a rapidly evolving field with significant implications for advanced manufacturing, biomedical applications, and more. ✨ 🌁…

Read more

On Monday, November 27th, the EU-funded ENLIGHT consortium convened at ETH Zürich in Basel 🇨🇭 a consortium meeting. With three years of dedicated work behind them and only a few months remaining, the project is nearing its conclusion. ENLIGHT is on a mission to revolutionize healthcare by integrating 3D printing, photonics, and synthetic biology to develop a bioprinted pancreas 🧬.…

Read more

Our bioprinting project to aid the development of new therapies for diabetes has been published in the Horizon Research & Innovation Magazine on August 23rd, 2024 with title '3D-printed living cells pave way for tomorrow's medicine and cruelty-free animal products'. Dr. Riccardo Levato, associate professor of biofabrication and regenerative medicine at the University Medical Center Utrecht and Utrecht University, is…

Read more

Our ENLIGHT young scientists proudly represented our team at the 7th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) in Seattle, USA June 25-28, 2024. They had the privilege to discuss the latest advancements within tissue engineering and regenerative medicine with fellow scientists, professors, and market experts. From left to right: Davide Ribezzi (UMCU), Oksana Dudaryeva…

Read more

On Wednesday, June 19th, and Thursday, June 20th, the EU-funded ENLIGHT consortium gathered at AstraZeneca in Gothenburg, Sweden. They reviewed the project's progress and innovations after three years of dedicated effort, with just one year remaining! 🇸🇪 ENLIGHT aims to revolutionize healthcare by combining 3D printing, photonics, and synthetic biology to create a bioprinted pancreas. 🧬 This groundbreaking technology could…

Read more

On Monday Nov 20th and Tuesday November 21st, the EU-funded ENLIGHT consortium convened at Rousselot in Ghent, Belgium. They discussed project progress and innovation after two and a half years of dedicated work (and only one and a half to go)! 🇧🇪 ENLIGHT is poised to advance healthcare by leveraging the fusion of 3D printing, photonics, and synthetic biology to develop a bioprinted pancreas. 🧬 This cutting-edge solution could…

Read more

Interested in the new field of Volumetric 3D Printing and how to print objects at once, without the constrains of layer-by-layer manufacturing? Have a look at our recent review lead by ENLIGHT partners EPFL (Jorge Madrid-Wolff, Christophe Moser) on materials for volumetric additive manufacturing, and co-written with UMCU (Paulina Nunez Bernal, Riccardo Levato and many more researchers in the Levato lab the…

Read more

On Friday, October 20th, UMCU hosted the Annual Meeting of the Dutch Society for Stem Cell Research. ENLIGHT Post Doctoral Researcher, Dr. Pere Catala presented the first preliminary results with bioprinting of iPSC-derived pancreatic islets! A big step for ENLIGHT and one of many to come as we pass the Month 30 mark and move into our final 1.5 years!

Read more

Meet ENLIGHT Researcher Martina Paladino, University of Naples “Federico II” (UNA), PhD student in Molecular Medicine and Medical Biotechnology! https://youtu.be/1pAlNR8ASJ8 Martina, what societal/medical issue does your research address? Within Enlight, my role is to test the functionality of bioprinted pancreatic organoids. Meanwhile I’m developing a reporter system to follow the commitment towards alpha and beta cells of stem cells. This…

Read more